Company news
Aytu BioPharma, Inc. news in 2020
Aytu BioPharma, Inc.'s news releases, calls and decks from 2020, newest first.
Aytu BioScience Announces Completion of Healight(TM) Safety Study in Critically Ill COVID-19 Patients
December 27, 2020
Aytu BioScience Announces Closing of $28.75 Million Bought Deal Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares
December 14, 2020
Aytu BioScience Increases Previously Announced Bought Deal Offering to $25.0 Million
December 9, 2020
Aytu BioScience Announces $10.0 Million Bought Deal Offering
December 9, 2020
Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue(1) Specialty Pharmaceutical Company
December 9, 2020
Aytu BioScience Announces Fiscal Q1 2021 Net Revenue of $13.5 Million, an Increase of 839% Year-Over-Year
November 11, 2020
Aytu BioScience to Report First Quarter Fiscal 2021 Results and Provide Business Update on Thursday, November 12, 2020
November 4, 2020
Aytu BioScience Announces Fiscal Q4 2020 Net Revenue of $14.9 Million, an Increase of 82% Sequentially, and 766% Year-Over-Year
October 5, 2020
Aytu BioScience to Report Fourth Quarter and Full Year Fiscal 2020 Results and Provide Business Update on Tuesday, October 6, 2020
October 4, 2020
Aytu BioScience to Reschedule Fourth Quarter and FY 2020 Conference Call
September 22, 2020
Aytu BioScience to Report Fourth Quarter FY 2020 Results and Business Update on Thursday, September 24, 2020
September 15, 2020
Aytu BioScience Announces Global Agreement to Distribute Pinnacle IVD Corporation's 15-Minute COVID-19 Antigen Test
September 7, 2020
Aytu BioScience Announces Launch of Nationwide Mobile COVID-19 Testing Initiative
August 18, 2020
Aytu BioScience Announces Manufacture and Delivery of Healight(TM) Devices for Use in COVID-19 Clinical Study
August 16, 2020
Aytu BioScience Announces Regulatory Approval of ZolpiMist(R) by Australian Therapeutic Goods Administration
July 29, 2020
Aytu BioScience Announces Expansion of NATESTO(R) U.S. Commercial Team
July 19, 2020
Aytu BioScience Announces Distribution Partnership with Apollo Med Innovations to Expand Distribution of COVID-19 IgG/IgM Rapid Test in United States
July 9, 2020
Aytu BioScience Announces Results from a National Cancer Institute Evaluation of the Company’s Licensed COVID-19 IgG/IgM Rapid Test
June 8, 2020
Aytu BioScience Set to Join Russell 3000(R) Index
June 7, 2020
Aytu BioScience Announces Significant Improvement in Natesto(R) Patient Access in the United States
June 2, 2020
Aytu BioScience Announces Emergency Use Authorization of COVID-19 IgG/IgM Rapid Test
May 31, 2020
Aytu BioScience Announces $15 Million Debt Retirement
May 31, 2020
Aytu BioScience Reports Third Quarter Fiscal 2020 Financial Results
May 13, 2020
Aytu BioScience to Report Fiscal Q3 FY 2020 Results and Business Update
May 6, 2020
Aytu BioScience Announces China Export Clearance of Company's COVID-19 IgG/IgM Rapid Test
April 29, 2020
Aytu BioScience Signs Development Agreement with Sterling Medical Devices to Advance the Development of Healight as a Potential Coronavirus Treatment
April 26, 2020
Aytu BioScience Announces Results from Annual Stockholders Meeting
April 23, 2020
Aytu BioScience Announces Exclusive Distribution Agreement for COVID-19 IgG/IgM Rapid Test with Singapore-Based Biolidics Limited
April 22, 2020
Aytu BioScience Announces Publication of Results from Natesto Spermatogenesis Study in Journal of Urology
April 20, 2020
Aytu BioScience Signs Exclusive Global License with Cedars-Sinai for Potential Coronavirus Treatment
April 19, 2020
Aytu BioScience Confirms Export and Incoming Delivery of COVID-19 IgG/IgM Rapid Tests
April 16, 2020
Aytu BioScience Announces Positive Results from an Independently Conducted Clinical Study of the Company's Licensed COVID-19 IgG/IgM Point-of-Care Rapid Test
April 15, 2020
Aytu BioScience Provides Update on its Licensed COVID-19 IgG/IgM Rapid Test Supply and Ongoing U.S. Distribution
April 14, 2020
Aytu BioScience Consumer Health Subsidiary Launches Regoxidine(R), an FDA Approved Hair Regrowth Treatment Foam that Contains 5% Minoxidil and Targets Over 11 Million U.S. Consumers Who Purchased Hair Regrowth Products in 2019
April 12, 2020
Aytu BioScience Announces Updated Annual Shareholder Meeting Date and Virtual Room Access
April 8, 2020
Aytu BioScience Announces Exclusive ZolpiMist(TM) License to Commercialize Aytu's Oral Spray Sleep Aid in South Korea
April 7, 2020
Aytu BioScience Receives $23.0 Million from Warrant Exercises
April 6, 2020
Aytu BioScience Announces First Commercial Shipment of its 2-10 Minute COVID-19 IgG/IgM Point-of-Care Rapid Test
April 2, 2020
Aytu BioScience Announces Receipt of Initial Shipment of 100,000 COVID-19 IgG/IgM Point-of-Care Rapid Tests; Additional 500,000 Tests on Order
March 31, 2020
AYTU Announces Delay of Annual Meeting of Stockholders Due to Colorado's "Shelter in Place" Order Related to the COVID-19 Crisis
March 29, 2020
Aytu BioScience Regains Compliance with NASDAQ Minimum Bid Price Requirement
March 24, 2020
Aytu BioScience Submits Notice of Commercialization to the FDA, Allowing for Company's Distribution of its 2-10 Minute COVID-19 IgG/IgM Point-of-Care Rapid Test
March 22, 2020
Aytu BioScience Expands Its Distribution Rights for Coronavirus 2019 (COVID-19) Point-of-Care Rapid Test to Canada and Mexico
March 18, 2020
Aytu Announces $20 Million Registered Direct Offering Priced At-the-Market
March 18, 2020
Aytu BioScience Announces Acceleration of U.S. Availability of COVID-19 IgG/IgM Rapid Test Based on Updated FDA Policy
March 16, 2020
Aytu BioScience Establishes COVID-19 IgG/IgM Rapid Test Product Inquiry Procedure for Healthcare Professionals and Institutions
March 12, 2020
Aytu Announces $9.0 Million Registered Direct Offering Priced At-the-Market
March 10, 2020
Aytu BioScience Secures Exclusive U.S. Distribution Agreement for Coronavirus 2019 (COVID-19) Point-of-Care Rapid Test
March 9, 2020
Aytu BioScience Completes Acquisition of Innovus Pharmaceuticals
February 17, 2020
Aytu Reports Q2 Revenue of $3.2M, Up 77% Year-over-Year and 121% Sequentially
February 12, 2020
Decks in 2020
- Aytu Bioscience — Merger or Acquisition (December 2020)
Merger or acquisition · 7 slides · Dec 15, 2020
- Aytu Bioscience — Merger or Acquisition (December 2020)
Merger or acquisition · 19 slides · Dec 10, 2020